Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Issue : The Pharmaceutical Journal, July 2011

Sort by: Newest first Oldest first A-Z Z-A

  • Starting antiretrovirals early helps prevent HIV spread

    22 JUL 2011 12:46

    Starting antiretroviral treatment early helps prevent the sexual transmission of HIV and delays the onset of HIV-related clinical events, new international research has shown.

  • Pharmaceutical innovation Subscription

    21 JUL 2011

    Gino Martini has been appointed to lead a new research group at King’s College London as professor of pharmaceutical innovation. Professor Martini is a fellow of the Royal Pharmaceutical Society.

  • Supply Issues - Fersaday (23 July 2011)

    21 JUL 2011 17:24

    Fersaday Fersaday (ferrous fumarate) tablets 100mg will be unavailable from Goldshield until the end of July 2011. Medical information on 08700 703033, stock-related information on 020 8588 9273.

  • Prescription Products (Arzerra, Hizentra, Paracetamol)

    21 JUL 2011 17:15

    ArzerraArzerra (ofatumumab) concentrate for solution for infusion 20mg/ml is now available from GlaxoSmithKline in a revised formulation containing an acetate-based buffer. These packs replace existing packs containing citrate buffer, which are available until stocks are exhausted. Net price: 3 x 100mg, £546; 1x 1,000mg, £1,820.  

  • SPC changes (Exelon, Ganfort, Ozurdex)

    21 JUL 2011 17:09

    ExelonExelon (rivastigmine; Novartis) can caused dose-related gastrointestinal disorders, including diarrhoea. Patients who show symptoms of dehydration resulting from prolonged vomiting or diarrhoea can be managed with intravenous fluids and dose reduction or discontinuation of treatment according to the updated summary of product characteristics.

  • Discontinued products (Cortisone acetate, Estradiol)

    21 JUL 2011 17:07

    Cortisone acetateCortisone acetate tablets 25mg have been discontinued by Sanofi-aventis. Further information on 01483 505515 (email uk-medicalinformation@sanofi-aventis.com).

  • Future events (contractual changes)

    21 JUL 2011 16:59

    The Pharmaceutical Services Negotiating Committee is holding a series of regional events to allow contractors to ask questions about the cost of service inquiry, the new medicine service and other changes to the pharmacy contract. Events will be held in July, August and September. Further details from the PSNC website.

  • Awards (Oncology)

    21 JUL 2011 16:57

    The Excellence in Oncology Awards 2011 are now open for entries from pharmacists and other healthcare professionals. Deadline for entries 29 July 2011. Further information from the Excellence in Oncology website.

  • Corrections (Sandocal +D 600)

    21 JUL 2011 16:53

    Sandocal +D600

  • Wants - Patient adherence

    21 JUL 2011 16:45

    Pharmacists are invited to share their approach to supporting patients with taking medicines and promoting adherence.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.